Literature DB >> 6107351

Long-lasting inhibition of platelet prostaglandin but normal vascular prostacyclin generation following sulphinpyrazone administration to rats.

M Livio, S Villa, G de Gaetano.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6107351     DOI： 10.1111/j.2042-7158.1980.tb13049.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN： 0022-3573            Impact factor:   3.765


× No keyword cloud information.
  4 in total

1.  Effects of ischaemic heart disease, Crohn's disease and antimicrobial therapy on the pharmacokinetics of sulphinpyrazone.

Authors:  H A Strong; R Angus; J Oates; J Sembi; P Howarth; A G Renwick; C F George
Journal:  Clin Pharmacokinet       Date:  1986 Sep-Oct       Impact factor: 6.447

2.  Alteration of monocrotaline pyrrole-induced cardiopulmonary effects in rats by hydrallazine, dexamethasone or sulphinpyrazone.

Authors:  K S Hilliker; R A Roth
Journal:  Br J Pharmacol       Date:  1984-06       Impact factor: 8.739

3.  The effect of prolonged treatment with sulphinpyrazone on thromboxane A2 and prostacyclin in man.

Authors:  L Viinikka; J Toivanen; O Ylikorkala
Journal:  Br J Clin Pharmacol       Date:  1982-09       Impact factor: 4.335

4.  A protective effect of sulphinpyrazone against coronary occlusion-induced shortening of myocardial refractory periods in the rat.

Authors:  B J Northover
Journal:  Br J Pharmacol       Date:  1986-05       Impact factor: 8.739
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.